Compare EXPD & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPD | DGX |
|---|---|---|
| Founded | 1979 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4B | 20.5B |
| IPO Year | N/A | 1996 |
| Metric | EXPD | DGX |
|---|---|---|
| Price | $156.68 | $178.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $126.40 | ★ $196.69 |
| AVG Volume (30 Days) | ★ 1.2M | 892.7K |
| Earning Date | 02-24-2026 | 01-29-2026 |
| Dividend Yield | 0.98% | ★ 1.77% |
| EPS Growth | ★ 20.10 | 14.49 |
| EPS | 6.15 | ★ 8.51 |
| Revenue | ★ $11,167,760,000.00 | $10,850,000,000.00 |
| Revenue This Year | $5.81 | $12.37 |
| Revenue Next Year | N/A | $3.52 |
| P/E Ratio | $25.62 | ★ $21.19 |
| Revenue Growth | 12.54 | ★ 13.74 |
| 52 Week Low | $100.47 | $148.70 |
| 52 Week High | $157.89 | $197.55 |
| Indicator | EXPD | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 67.14 | 48.32 |
| Support Level | $148.76 | $171.18 |
| Resistance Level | $157.89 | $176.37 |
| Average True Range (ATR) | 2.21 | 2.56 |
| MACD | -0.07 | 0.33 |
| Stochastic Oscillator | 85.98 | 66.78 |
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.